The Lobular Breast Cancer Alliance keeps its invasive lobular carcinoma (ILC) information and research cutting edge with the guidance of a Scientific Advisory Board (SAB) […]
LBCA’s Scientific Advisory Board Is Tackling ILC through Research Read More »
We are sad to announce that the 2nd ILC Symposium organizing committee – including the Lobular Breast Cancer Alliance advocates – have canceled the 2nd
2nd ILC Symposium and Lobular Advocate Boot Camp Canceled Read More »
May, 2020 by Priscilla F. McAuliffe MD PhD, Beth Z. Clark MD, Jennifer M. Xavier PhD, Steffi Oesterreich PhD, Rachel C. Jankowitz MD The unprecedented
Cancer Research Clinical Trials During the COVID-19 Pandemic Read More »
Postmenopausal women who have been diagnosed with invasive lobular breast cancer (ILC) who have not yet had surgery to remove their tumor may be eligible to participate in a multi-site clinical trial. This clinical trial will compare how lobular breast tumors respond to three different commonly prescribed, effective medications that are currently being used to treat breast cancer.Â
Clinical Trial: Endocrine Response in Pre-Surgical ILC Patients Read More »
Patients with Metastatic Lobular Breast Cancer (cancer has spread beyond the breast to other parts of the body) have a unique opportunity to advance critical research by participating in the Metastatic Breast Cancer Project’s ILC initiative.
Patients with ILC Mets Needed to Advance Research Read More »
The Lobular Breast Cancer Alliance sent several research advocates to participate in the 2019 San Antonio Breast Cancer Symposium. LBCA advocates submitted an abstract and
Lobular Research at the San Antonio Breast Cancer Symposium 2019 Read More »
The European Lobular Breast Cancer Consortium (ELBCC) seeks to increase collaboration and advance research into therapies for patients with lobular breast cancer (ILC).
ILC Research Consortium Forms in Europe, Includes Advocates Read More »
The American Association of Clinical Oncologists (ASCO) held its annual meeting in Chicago in June 2019. Two advocates from LBCA’s Steering Committee attended this leading
LBCA at ASCO 2019 Read More »
by LBCA Steering Committee member Diane Mapes (aka @double_whammied) At the 2019 American Association of Clinical Oncology (ASCO) annual meeting in Chicago, the LBCA was
Advocate’s Report ASCO 2019: Q & A with Dr. Peter Lucas Read More »
The Great Lakes Breast Cancer Symposium (GLBCS) was held May 2 – 4th, 2019 in Columbus Ohio. Three lobular advocates and steering committee members from
Great Lakes Breast Cancer Symposium: Video interviews with researchers, Advocates Read More »
The Lobular Breast Cancer Alliance and SHARE Cancer Support hosted an educational webinar:Â Research Updates on Metastatic Lobular Breast Cancer on November 13, 2019. Lobular
Webinar: Research Updates on Metastatic ILC Read More »
The Lobular Breast Cancer Alliance and SHARE Cancer Support partnered to present an educational presentation May 15th, 2019 entitled Lobular Breast Cancer: Understanding This Subtype
Webinar- Lobular Breast Cancer: Understanding This Subtype and its Treatment Read More »
Lobular Breast Cancer Alliance Inc. (LBCA) is a Delaware nonprofit corporation that is registered as a 501(c)(3) public charity. Tax ID Number: 86-2260246. Donations to LBCA are tax-deductible. to the fullest extent allowed by applicable law.
© 2024 The Lobular Breast Cancer Alliance Inc. | Privacy Policy | Terms of Use | State Fundraising Notices
Site by SuzanneHarrisonWeb.com
"*" indicates required fields